Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 12/2007

01-12-2007 | Original Article

Patterns of use of vascular access devices in patients undergoing hematopoietic stem cell transplantation: results of an international survey

Authors: Juan J. Toro, Manuel Morales, Fausto Loberiza, Jose L. Ochoa-Bayona, Cesar O. Freytes

Published in: Supportive Care in Cancer | Issue 12/2007

Login to get access

Abstract

Introduction

There is limited information regarding of use of vascular access devices (VAD) in patients undergoing hematopoietic stem cell transplantation (HSCT). The frequent use of VAD in HSCT and its potential to cause morbidity requires understanding of the general use of VAD in HSCT.

Materials and methods

A World Wide Web-based 19-item questionnaire was designed to determine the patterns of use of VAD in patients undergoing HSCT. The questionnaire was sent via electronic mail to the directors of HSCT programs throughout the world.

Results

Of the 445 centers surveyed, 163 centers replied for a response rate of 37%. The most commonly used catheter for autologous peripheral blood stem cell (PBSC) harvest is the dual-lumen plasmapheresis/hemodialysis (62%). Of the institutions, 58% utilize the same catheter used for PBSC harvest to provide vascular access support during the transplant. Catheter-related blood stream infection (36%) and withdrawal occlusion (31%) were the most frequently encountered complications of VAD. Of the centers, 65% have established criteria for VAD removal when infection is suspected and 48% when occlusion is suspected.

Discussion

Our study demonstrated that there are similarities in the utilization of VAD but also wide differences in the standard procedures for the insertion and care of VAD in the transplant setting. More comprehensive studies are needed to assess the use of central venous catheters in transplant recipients. Important areas for future research include the impact of VAD utilization on the quality of life of transplant recipients and the final consequences of VAD complications.
Literature
1.
Couban S, Goodyear M, Burnell B, Dolan S, Wasi P, Barnes D, MacLeod D, Burton E, Andreou P, Anderson DR (2005) Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer. J Clin Oncol 23:4063–4069PubMedCrossRef
2.
Cunningham MS, White B, Hollywood D, O’Donell J (2006) Primary thromboprophylaxis for cancer patients with central venous catheters—a reappraisal of the evidence. Br J Cancer 94:189–194PubMedCrossRef
3.
Gaitini D, Beck-Razi, Haim N, Brenner B (2006) Prevalence of upper extremity deep venous thrombosis diagnosed by color Doppler duplex sonography in cancer patients with central venous catheters. J Ultrasound Med 25:1297–1303PubMed
4.
Hachem R, Raad I (2002) Prevention and management of long-term catheter related infections in cancer patients. Cancer Invest 20:1105–1113PubMedCrossRef
5.
Johansson E, Sollen Hansson M, Nilson A, Engervall P (1999) Vascular devices used during harvest of peripheral blood stem cells: high complication rate in patients with long-term dialysis central venous catheter. Bone Marrow Transplant 24:793–797PubMedCrossRef
6.
Linenberger ML (2006) Catheter-related thrombosis: risks, diagnosis and management. J Natl Compr Cancer Netw 4:889–901
7.
McDermott MK (1995) Patient education and compliance issues associated with access devices. Semin Oncol Nurs 11:221–226PubMedCrossRef
8.
Mey U, Glasmacher A, Hahn C, Gorschluter M, Ziske C, Mergerlsberg M, Sauerbruch T, Schmidt-Wolf IG (2003) Evaluation of an ultrasound-guided technique for central venous access via the internal jugular vein in 493 patients. Support Care Cancer 11:148–155PubMed
9.
Morales M, Dorta J (1994) Percutaneous insertion of Hickman catheters while the patient is in bed: a simplification of the technique. Support Care Cancer 2:270–271PubMedCrossRef
10.
O’Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, Masur H, McCormick RD, Mermel LA, Pearson ML, Raad II, Randolph A, Weinstein RA; Healthcare Infection Control Practices Advisory Committee (2002). Guidelines for the prevention of intravascular catheter-related infections. Infect Control Hosp Epidemiol 23:759–769PubMedCrossRef
11.
Raaf JH (1994) Administration of chemotherapeutic agents. Techniques and controversies. Support Care Cancer 2:335–346PubMedCrossRef
12.
Restrepo A, Devore P, Encarnacion CE, Wholey MH, Schneider D, Callander NS, Ferral H, Postoak D, Anderson JE, Walsh T, Padayao G, Gokmen E, Ehsan A, Ochoa L, Neumon B, West G, Restrepo MI, Przykucki J, Patterson J, Freytes CO (2002) Performance of a hybrid central venous catheter utilized for both peripheral blood stem cell harvest and transplant support of patients undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 30:389–395PubMedCrossRef
13.
Sadler DJ, McCarthy M, Saliken JC, So CB, Klassen J, Selinger S, Grey RR (2000) Image-guided central venous catheter placement for apheresis in allogeneic stem cell donors. J Clin Apher 15:173–175PubMedCrossRef
14.
Verso M, Agnelli G (2003) Venous thromboembolism associated with long-term use of central venous catheters in cancer patients. J Clin Oncol 21:3665–3675PubMedCrossRef
15.
Verso M, Agnelli G, Bertoglio S, DiSoma FC, Paoletti F, Ageno W, Bazzan M, Parise P, Quintavalla R, Naglieri E, Santoro A, Imberti D, Soraru M, Mosca S (2005) Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: a double-blind, placebo-controlled, randomized study in cancer patients. J Clin Oncol 23:4057–4062PubMedCrossRef
Metadata
Title
Patterns of use of vascular access devices in patients undergoing hematopoietic stem cell transplantation: results of an international survey
Authors
Juan J. Toro
Manuel Morales
Fausto Loberiza
Jose L. Ochoa-Bayona
Cesar O. Freytes
Publication date
01-12-2007
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 12/2007
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-007-0261-8

Other articles of this Issue 12/2007

Supportive Care in Cancer 12/2007 Go to the issue

Original Article

Symptom and medication profiles among cancer patients attending a palliative care clinic

Original Article

Psychological distress of female cancer caregivers: effects of type of cancer and caregivers’ spirituality

Original Article

An extended maintenance dosing regimen of epoetin alfa 80,000 U every 3 weeks in anemic patients with cancer receiving chemotherapy

Original Article

Sources of strength perceived by females caring for relatives diagnosed with cancer: an exploratory study from India

Original Article

Oxidative stress in lymphocytes, neutrophils, and serum of oral cavity cancer patients: modulatory array of l-glutamine

Original Article

Stress and long-term survivors of brain cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits